Thank you for participating in this program. Please answer the questions below to receive credit.

Question Title

* 1. EVALUATION:
How would you rate this activity overall? (4 being the highest and 1 being the lowest)

Question Title

* 2. I am a/an: (SELECT ONE)

Question Title

* 3. My main practice setting is:

Question Title

* 4. How many patients with B-cell malignancies do you encounter per month?

Question Title

* 5. Please answer the following:
4-Strongly Agree  3-Agree  2-Disagree  1-Strongly Disagree

  4 3 2 1
The faculty presenter was effective
The faculty presenter was knowledgeable
The information the faculty presented was high quality

Question Title

* 6. Comments:

Question Title

* 7. As a result of attending this activity, I am better able to:
4-Strongly Agree  3-Agree  2-Disagree  1-Strongly Disagree

  4 3 2 1
Describe the role of the BCR (B-cell receptor) pathway in malignant B-cell survival.
Explore the therapeutic rationale for targeting the BCR pathway in CLL and other B-cell malignancies.
Assess the latest safety and efficacy data for BTKis (BTK inhibitors) in TN (treatment-naïve) and R/R (relapsed/refractory) CLL and examine strategies to overcome resistance seen in these agents.
Using a case-based approach, appraise effective strategies to integrate BTK inhibitors into the CLL treatment paradigm, recognize and appropriately manage adverse events, and answer challenging clinical issues pharmacists may encounter in their practice.

Question Title

* 8. Please answer the following:
4-Strongly Agree  3-Agree  2-Disagree  1-Strongly Disagree

  4 3 2 1
The teaching and learning methods were effective.
Educational materials provided were/will be useful to me (i.e., slides and suggested reading).
This activity met my professional/educational needs.

Question Title

* 9. Please answer yes or no to the following:

  Yes No
Overall, did the activity meet the stated learning objectives?
The information presented was new and/or useful.
As a result of attending this activity, I can improve the practice of my interprofessional team.
The activity was free of commercial bias.

Question Title

* 10. Comments:

Question Title

* 11. What is one key learning that you will share with your interprofessional team?

Question Title

* 12. Will the information presented cause you to make any changes to your current practice?

Question Title

* 13. If yes, what types of practice changes do you plan to implement with your healthcare team? (CHECK ALL THAT APPLY):

Question Title

* 14. What barriers do you encounter in practice that prevent you from making changes? (CHECK ALL THAT APPLY)

Question Title

* 15. Activity Comments/Suggestions for Future Activities:

Question Title

* 16. How has your clinical practice changed since the COVID-19 outbreak? What concerns or issues have you encountered with patient care?

Question Title

* 18. To receive credit, please enter the following information. Please include credentials in Name.

T